Morgan Stanley
ENZN

Morgan Stanley’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Morgan Stanley’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,600
Closed -$2K – 6886
2016
Q1 		$2K Sell
4,600
-81,356
-95% -$39.7K ﹤0.01% 6441
2015
Q4 		$58K Sell
85,956
-90,096
-51% -$71.4K ﹤0.01% 5655
2015
Q3 		$171K Buy
176,052
+11,964
+7% +$14.7K ﹤0.01% 5161
2015
Q2 		$197K Buy
164,088
+83,209
+103% +$106K ﹤0.01% 5243
2015
Q1 		$85K Sell
80,879
-36,709
-31% -$38K ﹤0.01% 5595
2014
Q4 		$128K Sell
117,588
-71,465
-38% -$75K ﹤0.01% 5445
2014
Q3 		$204K Sell
189,053
-86,579
-31% -$107K ﹤0.01% 5132
2014
Q2 		$287K Sell
275,632
-145,009
-34% -$138K ﹤0.01% 4962
2014
Q1 		$432K Buy
420,641
+81,336
+24% +$84K ﹤0.01% 4655
2013
Q4 		$394K Sell
339,305
-29,734
-8% -$45.8K ﹤0.01% 4622
2013
Q3 		$621K Buy
369,039
+37,892
+11% +$70.1K ﹤0.01% 4184
2013
Q2 		$663K Buy
+331,147
New +$969K ﹤0.01% 4056

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $409M AUM 17.6% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Morgan Stanley's ENZN Position: Q2 2016 in Review

Morgan Stanley sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 4,600 shares — an estimated $2K sold.

Morgan Stanley first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $663K in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Morgan Stanley reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Morgan Stanley sold 4,600 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $2K.
  • Morgan Stanley first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • Morgan Stanley's ENZON PHARMACEUTICALS INC position peaked at $663K in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.